Nuwellis, Inc. (NUWE)
NUWE moved a median of -0.38% 30 minutes after news, and -1.85% by the close. How NUWE actually reacts to news — the realized, point-in-time move the market made, measured across 307 labeled events over the last three years with zero look-ahead.
NUWE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.05% | 37% | 301 |
| 30-min | -0.38% | 43% | 304 |
| 60-min | -0.98% | 35% | 306 |
| to close | -1.85% | 32% | 302 |
| Middle 50% of NUWE reactions | -3.89% to +2.05% |
|---|---|
| Median reaction (30-min) | -0.38% |
| Measured reactions | 307 |
Half of all Nuwellis, Inc. news events land between -3.89% and +2.05% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NUWE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NUWE's baseline. Nothing else.
Recent NUWE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System | Press release | GlobeNewswire | -0.98% | -3.56% | |
| Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences | Press release | GlobeNewswire | +2.44% | +0.97% | |
| Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity | Press release | GlobeNewswire | +2.45% | +27.38% | |
| Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs | Press release | GlobeNewswire | +2.70% | +1.18% | |
| Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins | Press release | GlobeNewswire | +1.73% | +1.70% | |
| Form EFFECT Nuwellis, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +2.06% | +1.96% | |
| Form 8-K Nuwellis, Inc. For: Aug 25 | SEC filing · Form 8-K | SEC EDGAR | -3.77% | -4.72% | |
| Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical | Press release | GlobeNewswire | -0.94% | -9.51% | |
| Form S-3 Nuwellis, Inc. | SEC filing · Form S-3 | SEC EDGAR | +1.71% | +0.00% | |
| Form 10-Q Nuwellis, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.51% | -0.76% | |
| Form 8-K Nuwellis, Inc. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +1.51% | -0.76% | |
| Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin | Press release | GlobeNewswire | +0.36% | -5.80% | |
| Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface | Press release | GlobeNewswire | +5.25% | +3.50% | |
| Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer | Press release | GlobeNewswire | -2.35% | -4.12% | |
| Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications | Press release | GlobeNewswire | -7.51% | -11.74% | |
| Form 8-K Nuwellis, Inc. For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | -7.51% | -11.74% | |
| Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | Press release | GlobeNewswire | -0.85% | -1.70% | |
| Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy | Press release | GlobeNewswire | +7.53% | -14.09% | |
| Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth | Press release | GlobeNewswire | -6.00% | -0.50% | |
| Form 8-K Nuwellis, Inc. For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | -6.00% | -0.50% | |
| Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies | Press release | GlobeNewswire | -1.14% | -4.54% | |
| Form DEF 14A Nuwellis, Inc. For: Jul 07 | SEC filing · Form DEF | SEC EDGAR | -1.83% | -4.65% | |
| Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 | Press release | GlobeNewswire | -0.92% | -3.96% | |
| Form PRE 14A Nuwellis, Inc. For: Jul 24 | SEC filing · Form PRE | SEC EDGAR | +1.35% | -3.64% | |
| Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC4) | Press release | GlobeNewswire | -2.57% | -5.71% | |
| Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations | Press release | GlobeNewswire | -3.67% | +2.16% | |
| Form 8-K Nuwellis, Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | -1.45% | -0.89% | |
| Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders | Press release | GlobeNewswire | -1.45% | -0.89% | |
| Form 8-K Nuwellis, Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | -1.84% | |
| Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit | Press release | GlobeNewswire | -0.15% | -1.84% | |
| Nuwellis Appoints Mike McCormick as Chief Executive Officer | Press release | GlobeNewswire | +0.90% | +1.27% | |
| Form 8-K Nuwellis, Inc. For: Jun 08 | SEC filing · Form 8-K | SEC EDGAR | -1.10% | +1.33% | |
| Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals | Press release | GlobeNewswire | -1.10% | +1.33% | |
| Nuwellis Announces Closing of $6.0 Million Registered Public Offering | Press release | GlobeNewswire | -3.42% | -2.55% | |
| Form EFFECT Nuwellis, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -4.00% | -1.65% | |
| Form S-1MEF Nuwellis, Inc. | SEC filing · Form S-1MEF | SEC EDGAR | -4.00% | -1.65% | |
| Nuwellis Announces Pricing of $6 Million Public Offering | Press release | GlobeNewswire | -4.00% | -1.65% | |
| Form S-1/A Nuwellis, Inc. | SEC filing · Form S-1 | SEC EDGAR | -8.46% | -2.44% | |
| Form S-1/A Nuwellis, Inc. | SEC filing · Form S-1 | SEC EDGAR | +5.74% | -4.10% | |
| Form SD Nuwellis, Inc. | SEC filing · Form SD | SEC EDGAR | +0.00% | +14.14% | |
| Form S-1 Nuwellis, Inc. | SEC filing · Form S-1 | SEC EDGAR | -1.11% | +0.79% | |
| Form 10-Q Nuwellis, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.98% | -2.12% | |
| Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label | Press release | GlobeNewswire | +2.80% | -4.67% | |
| Form 8-K Nuwellis, Inc. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | -2.83% | -2.83% | |
| Nuwellis, Inc. Announces First Quarter 2026 Financial Results | Press release | GlobeNewswire | -0.15% | -0.96% | |
| Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026 | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 8-K Nuwellis, Inc. For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.42% | |
| Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting | Press release | GlobeNewswire | +0.89% | -0.89% | |
| Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology | Press release | GlobeNewswire | +0.88% | -2.63% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NUWE section they belong to.
Where else NUWE is measured.
NUWE earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Nuwellis, Inc.'s median reaction calculated?
Every labeled NUWE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 307 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of NUWE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NUWE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.